BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2017
View Archived Issues
GD116 demonstrates enhanced antitumor efficacy in human breast cancer models
Read More
U.S. Dept. of Health & Human Services describes FLT3-specific chimeric antigen receptors
Read More
EpiVax receives grant to develop therapy for Graves disease
Read More
Promising phase I data for CK-2127107 in healthy subjects
Read More
Rhizen's tenalisib given orphan drug designation for peripheral T-cell lymphoma
Read More
FDA gives Cu(II)-ATSM orphan drug status for ALS
Read More
Eloxx Pharmaceuticals and Sevion Therapeutics complete acquisition
Read More
JSR Corporation to acquire Crown Bioscience International
Read More
Novel SCN2A gene mutations tied to intractable epilepsy
Read More
First clinical results reported for CAR T cells targeting CD123
Read More
Ticagrelor well tolerated in phase II pediatric sickle cell disease trial
Read More
Loxo Oncology starts rolling NDA submission for larotrectinib
Read More
TARIS and BMS agree to test combination therapy for muscle invasive bladder cancer
Read More
Arrowhead Pharmaceuticals applies to conduct first-in-human study of ARO-AAT
Read More
Cadent Therapeutics identifies novel potassium channel modulators
Read More
New parkin modulators divulged by An2H Discovery
Read More
The University of Texas discloses novel SHP-2 inhibitors
Read More
NuCana BioMed discovers new cladribine derivatives
Read More
FDA approves Macrilen for diagnosis of adult growth hormone deficiency
Read More
FDA expands Opdivo indication
Read More
FDA approves Perjeta for adjuvant treatment of HER2-positive early breast cancer
Read More
AbbVie reports topline results from phase III study of upadacitinib
Read More
Aivita initiates phase II autologous cancer immunotherapy study in ovarian cancer
Read More
FDA grants QIDP designation to ceftobiprole for S. aureus bacteremia
Read More
FDA accepts Seysara NDA for moderate to severe acne
Read More
UCB reports phase IIb data on bimekizumab in psoriatic arthritis
Read More
